About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New ‘Adjuvant’ Could Possibly Become A Universal Vaccine Carrier

by Aruna on September 17, 2009 at 10:40 AM
Font : A-A+

New ‘Adjuvant’ Could Possibly Become A Universal Vaccine Carrier

In a novel study, scientists at Oregon State University have developed a new 'adjuvant' that would allow the creation of important new vaccines for various diseases.

It can possibly become a universal vaccine carrier, and help medical experts tackle many diseases more effectively.

Advertisement

Adjuvants are substances that are not immunogenic themselves, but increase the immune response when used in combination with a vaccine.

However, due to concerns about safety and toxicity, there's only a single vaccine adjuvant - aluminum hydroxide, or alum, that has been approved for human use.
Advertisement

It's found in such common vaccines as hepatitis B and tetanus.

The new adjuvant is based on nanoparticles prepared with lecithin, a common food product.

The study conducted over animal models showed that it helped protein antigens to induce an immune response more than six times stronger than when alum was used.

The researchers also showed that the lecithin nanoparticles were able to help induce a reasonable antibody response after only one shot, whereas it took at least two shots for the alum adjuvant to work.

"In many cases, to make progress with vaccine development we need new adjuvants," said Zhengrong Cui, an assistant professor of pharmaceutics at OSU and corresponding author on the new study.

"The material has to be safe, and lecithin is a common food product that's already widely used in pharmaceuticals.

"This new form of using lecithin nanoparticles as an adjuvant is promising and could become very important.

"Our early studies with laboratory animals seem to suggest that a vaccine based on the lecithin nanoparticle adjuvant would not only be more effective, but be tolerated by the body more readily than one using alum.

"Lecithin is very non-toxic, it's one of many compounds 'generally recognized as safe' by the FDA, and at the injection site we saw none of the nodules and tissue hardening you sometimes see with vaccines that use alum," Cui added.

If the new adjuvant is ultimately shown to be safe and is approved following clinical trials, Cui said, it could become the basis for a revolution in the production of vaccines and serve as a universal carrier.

The findings have been published in the Journal of Controlled Release.

Source: ANI
ARU
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Top 10 Vaccine Myths Debunked 

Most Popular on Medindia

Hearing Loss Calculator Selfie Addiction Calculator Pregnancy Confirmation Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Loram (2 mg) (Lorazepam) Drug - Food Interactions Blood Donation - Recipients Diaphragmatic Hernia How to Reduce School Bag Weight - Simple Tips Blood - Sugar Chart
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New ‘Adjuvant’ Could Possibly Become A Universal Vaccine Carrier Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests